TAIWANESE HEALTH AND RESEARCH DELEGATION VISIT PARATUS CLINICAL TRIAL SITE IN CANBERRA Visit fosters greater collaboration and experience of clinical trial execution in public and private health settings best practice
With
Matt Clacy,
Founder & Chief Commercial Officer
Paratus Clinical
Dr Amber Leah,
Principal Investigator & Medical Director
Paratus Clinical
Professor Chun-Jen Huang,
Dean of Office of Human Research
Taipei Medical University & Taipei Municipal Wanfang Hospital
Taiwan
Professor Pin-Kuei Fu,
Director, Clinical Research Center
Taichung Veterans General Hospital
Taiwan
AUSTRALIAN HEALTH JOURNAL SEGMENT
Filmed in Canberra | September 2025
In late August 2025, a Taiwanese delegation comprising government officials from the Taiwanese FDA, various governmental groups, and physicians and researchers from across Taiwan, visited Paratus Clinical’s trial site in Canberra. Their objective was to explore both the differences and similarities between the clinical research ecosystems of Taiwan and Australia.
Throughout the discussions, the delegation learned about the processes involved in initiating research, the regulatory hurdles that must be navigated, and the practicalities of conducting clinical trials in both public and private sectors.
Paratus Clinical specialises in a range of clinical trials, from Phase I to Phase III, including vaccine studies and treatments across primary care areas such as asthma, diabetes, and cardiometabolic health, as well as outpatient specialties like dermatology and oncology.
The conversations also addressed the distinctions between inpatient and outpatient care, focusing on startup timelines, regulatory requirements, and patient recruitment strategies. Notably, the delegation found a reassuring number of similarities in clinical practice between the two countries.
Matt Clacy, recognised the potential benefit of fostering greater collaboration between public and private sectors in Australia, a practice that is more prevalent in Taiwan and advantageous for patient care and the healthcare system overall.
Source: Written by AUDIENCED
-
Valuing the Contribution of Exercise Physiologists in Australia
Exercise physiologists are saving the Australian health system at least $940 million across six chronic health conditions every three years, a Deloitte Access Economics report has found.
Backed by three decades of rigorous peer-reviewed science, exercise physiology delivers services to 243,000 Australians per week, translating to more than 1.16 million unique patients annually, primarily through 9,800 Accredited Exercise Physiologists (AEPs) nationwide.
-
Medical research institutes association responds to draft national research strategy
On 27 August 2025, the Minister for Health, Disability and Ageing announced the release of the draft National Health and Medical Research Strategy (the National Strategy).
Involved in the initial consultation phase, was the Association of Australian Medical Research Institutes (AAMRI), the peak body for medical research institutes across Australia. Member institutes work on a broad spectrum of human health issues such as preventive health, chronic disease, mental health, immunology and Indigenous health. Their research ranges from fundamental biomedical discovery through to clinical research and the translation of research findings.
-
Emerging researcher appointed to James Packer Chair in Mood Disorders at UNSW
The UNSW Discipline of Psychiatry and Mental Health is widely renowned as the pre-eminent psychiatry research department in the country and one of the leading university psychiatry research groups internationally. In 2023 it celebrated 60 Years of Psychiatry & Mental Health at UNSW Sydney.
Australian Health Journal spoke with Professor Kimberlie Dean, Head of the Discipline of Psychiatry and Mental Health at UNSW Sydney, about the recent appointment of mental health disorders expert and clinician researcher Dr Aswin Ratheesh to lead the James Packer Chair in Mood Disorders at UNSW Sydney.
